BioCOS Life Sciences Private Limited

www.biocosls.com & www.biocosls.in


Registered with Ministry of Corporate Affairs (MCA) India and head office at Bangalore, India is a DSIR(Department of Scientific & Industrial Research, Ministry of Science & Technology, Govt. of India) recognized R&D company in computational life sciences areas with many international and national R&D collaborations, research publications and IPs.

More Information is being uploaded. Please contact us for further details on our services/products/research

BioCOS Life Sciences Private Limited
Biotech Park ( Behind 3M, IBAB Campus)
Electronics City, Phase-1
Bangalore, Karnataka 560100
India

ph: +91 80 28 523 930 / 929
fax: +91 80 28 523 929

info@biocosls.in

  • ResearchClick to open the Research menu
    • Next Generation Sequencing (NGS)
    • smallRNA
    • Systems Biology
    • Bio Image Analysis
    • Publications & Patents
    • R&D Collaborators and Associations
  • Disease Specific FocusClick to open the Disease Specific Focus menu
    • Diabetes ( T2D &T1D)
    • Metabolic Syndrom Diseases (MSD)
    • Cancer Specific
    • Malaria
  • Products
  • ServicesClick to open the Services menu
    • Computational Genomics & NGS Data Analysis/Algorithms
    • Systems Biology
    • Metabolic Syndrom Diseases (MSD)
    • Microarray Data Analysis
    • Molecular Modelling and Docking
    • TRAINING
  • Career/Jobs
  • Contact Us
  • About Us
  • Home

Diabetes ( T2D &T1D)

Our research is focused on the various diseases and development of computational systems and methodologies to effectively understand their complexities. These approaches are being used to develop our in house technologies and also to aid our customers in the development of biomarkers, disease diagnosis etc.

Diseases

  1. Diabetes Type-1 & Type-2

    Diabetes is a polygenic metabolic disorder and its progression in the patients lead to several other organ complications. BioCOS researches and develops analysis protocols/products to analyze and simulate this metabolic syndrome from different types of molecular data.

    We are working on Analyzing pathways, Candidate Genes, Building systems biology networks using a vast and curated knowledgebase of diabetes specific genes and pathways. The entire analysis is conducted in a BioCOS's automated statistical pipeline tool, which supports various types of input data and data formats

    Case Studies (Related publications)

    • Expression-based network biology identifies alteration in key regulatory pathways of Type 2 Diabetes and associated risk/complications (PLoS ONE, December 2009 | Volume 4 | Issue 12).
    • An integrated network biology approach identifies transcriptionally altered pathways indicating risk of cardiovascular diseases in Diabetes Type II condition. APBC 2010 (The Eighth Asia Pacific Bioinformatics Conference), Bangalore, India, 18-21 January 2010.).
    • Significant deregulated pathways in Diabetes type II complications identified through expression based network biology. IC3 2009, CCIS 40, pp. 445 - 453, 2009

Copyright 2011 BioCOS Life Sciences. All rights reserved.

BioCOS Life Sciences Private Limited
Biotech Park ( Behind 3M, IBAB Campus)
Electronics City, Phase-1
Bangalore, Karnataka 560100
India

ph: +91 80 28 523 930 / 929
fax: +91 80 28 523 929

info@biocosls.in